Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 121.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 150.00
  • 52 Week Low: 96.50
  • Currency: UK Pounds
  • Shares Issued: 84.77m
  • Volume: 0
  • Market Cap: £102.58m
  • RiskGrade: 196
  • Beta: 0.00

Diaceutics Overview

Diaceutics is a data analytics and implementation services company which services the global pharmaceutical industry. It has established a suite of data-driven products and implementation services powered by the data held in its proprietary database. Its products and services are focused on optimising its clients’ strategies for the development and launch of precision medicines and specifically, the diagnostic testing required to guide selection of such medicines. The Group currently provides services to 20 of the 30 largest global pharmaceutical companies.

1 Day Chart (01-04-2025)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -12.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 4.3 n/a
Pr/Book 2.5  
Latest F'cast
Revenue 21.5% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Diaceutics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 13.44 0.50 2.46p 41.5 1.3 +32% n/a 0.0%
31-Dec-20 12.70 (0.68) 0.74p 180.4 n/a -70% n/a 0.0%
31-Dec-21 13.94 0.46 0.67p 152.2 n/a -10% n/a 0.0%
31-Dec-22 19.50 0.56 0.86p 87.8 3.1 +28% n/a 0.0%
31-Dec-23 23.70 (2.44) (2.07)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Diaceutics Company Announcements

PMx Promotional Partner Contract Enhancement 26-Mar-2025 07:00 RNS
Holding(s) in Company 06-Mar-2025 15:16 RNS
PDMR Shareholding/Share Incentive Plan and TVR 03-Mar-2025 15:00 RNS

Latest Diaceutics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 121.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 150.00
52 Week Low 96.50
Volume 0
Shares Issued 84.77m
Market Cap £102.58m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.86% below the market average32.86% below the market average32.86% below the market average32.86% below the market average32.86% below the market average
57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average57.58% below the sector average
Price Trend
48.17% above the market average48.17% above the market average48.17% above the market average48.17% above the market average48.17% above the market average
78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average78.38% above the sector average
Income Not Available
Growth
35.07% above the market average35.07% above the market average35.07% above the market average35.07% above the market average35.07% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average

Diaceutics Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page